New biomarker development, e.g. imaging or serum parameters |
Translational toxicology including more powerful biomarkers |
Biomarker scoring systems to grade their predictive potency |
Smart, early human study design, including novel approaches e.g. microdosing and descriptive trials |
Biostatistics development to cope with multiple read-out problems and small human studies |
Human genetics |